On the heels of Se­ries A, Nom­ic will join Broad In­sti­tute con­sor­tium and ex­pand ac­cess to plat­form

Nom­ic is try­ing to de­vel­op the world’s high­est through­put pro­teom­ic plat­form. It will now do so with an­oth­er $17 mil­lion in tow.

The Mon­tre­al-based com­pa­ny an­nounced the clos­ing of its Se­ries A fi­nanc­ing round Wednes­day that was led by Lux Cap­i­tal, SR One  and Cas­din Cap­i­tal. The funds will be used to help build the nELISA, a scal­able form of ELISA — the decades-old tech­nique for de­tect­ing pro­teins in a sam­ple — that us­es ad­vances in DNA nan­otech­nol­o­gy, an imag­ing tech­nique called spec­tral mul­ti­plex­ing, and au­toma­tion to bring a scal­able and gen­er­al­iz­able ap­proach to mul­ti­plexed pro­tein quan­tifi­ca­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER